Cargando...

ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系

BACKGROUND AND OBJECTIVE: Anaplastic lymphoma kinase (ALK) is one of the major driver genes of non-small cell lung cancer (NSCLC). Several studies have shown that the efficacy of pemetrexed in ALK-positive lung cancer is controversial. The aim of this study is to explore the efficacy of pemetrexed-b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Zhongguo Fei Ai Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado: 中国肺癌杂志编辑部 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5973278/
https://ncbi.nlm.nih.gov/pubmed/29167001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.02
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!